A detailed history of Perkins Capital Management Inc transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 797,602 shares of AZYO stock, worth $1.16 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
797,602
Previous 778,502 2.45%
Holding current value
$1.16 Million
Previous $1.68 Million 31.27%
% of portfolio
1.0%
Previous 1.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
N/A
19,100 Added 2.45%
797,602 $1.16 Million
Q4 2023

Jan 22, 2024

BUY
$1.14 - $1.45 $491,686 - $625,390
431,304 Added 124.22%
778,502 $1.68 Million
Q3 2023

Nov 02, 2023

SELL
$1.13 - $2.52 $1,977 - $4,410
-1,750 Reduced 0.5%
347,198 $496,000
Q2 2023

Jul 21, 2023

BUY
$1.41 - $2.79 $103,802 - $205,397
73,619 Added 26.74%
348,948 $824,000
Q1 2023

May 09, 2023

BUY
$1.19 - $4.96 $19,337 - $80,600
16,250 Added 6.27%
275,329 $416,000
Q4 2022

Jan 26, 2023

BUY
$3.48 - $8.94 $141,810 - $364,305
40,750 Added 18.66%
259,079 $1.1 Million
Q3 2022

Oct 24, 2022

SELL
$5.72 - $7.76 $48,048 - $65,184
-8,400 Reduced 3.7%
218,329 $1.57 Million
Q2 2022

Jul 29, 2022

SELL
$5.75 - $7.41 $5,750 - $7,410
-1,000 Reduced 0.44%
226,729 $1.6 Million
Q4 2021

Feb 10, 2022

SELL
$4.1 - $6.82 $2,853 - $4,746
-696 Reduced 0.3%
227,729 $1.44 Million
Q3 2021

Oct 25, 2021

BUY
$6.75 - $9.52 $499,500 - $704,480
74,000 Added 47.92%
228,425 $1.59 Million
Q2 2021

Jul 28, 2021

BUY
$9.51 - $13.97 $147,405 - $216,535
15,500 Added 11.16%
154,425 $1.48 Million
Q1 2021

Apr 28, 2021

SELL
$13.08 - $16.41 $5,886 - $7,384
-450 Reduced 0.32%
138,925 $1.92 Million
Q4 2020

Feb 09, 2021

BUY
$10.77 - $14.82 $1.5 Million - $2.07 Million
139,375 New
139,375 $1.9 Million

Others Institutions Holding AZYO

About AZIYO BIOLOGICS, INC.


  • Ticker AZYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,308,720
  • Market Cap $13.5M
  • Description
  • Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...
More about AZYO
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.